Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 15

Results For "Diabetes"

576 News Found

CARE Hospitals performs rare organ-preserving pancreatic surgery
Hospitals | May 07, 2026

CARE Hospitals performs rare organ-preserving pancreatic surgery

Complex tumour removed in a young patient without major pancreatic loss, reducing risk of lifelong diabetes


Novo Nordisk posts strong Q1 as Wegovy drives global GLP-1 momentum
News | May 07, 2026

Novo Nordisk posts strong Q1 as Wegovy drives global GLP-1 momentum

The standout story remains Wegovy, particularly its new oral formulation


Eli Lilly unveils $4.5 bn Indiana expansion
News | May 07, 2026

Eli Lilly unveils $4.5 bn Indiana expansion

The investment will upgrade and expand production capabilities at Lilly Lebanon API and Lilly Lebanon Advanced Therapies


MedVital raises Rs. 18 crore to scale medical technologies in advanced wound care
Medical Device | May 06, 2026

MedVital raises Rs. 18 crore to scale medical technologies in advanced wound care

The company has also launched Elyara, a portfolio of products in regenerative medical aesthetics focused on non-invasive skin and hair restoration


OBESITAS 2026 concludes with focus on India’s rising obesity burden
Healthcare | May 05, 2026

OBESITAS 2026 concludes with focus on India’s rising obesity burden

The conference brought together over 500 doctors and 150 nutritionists to discuss emerging obesity-related challenges


OneSource powers second generic semaglutide nod in Canada
Drug Approval | May 05, 2026

OneSource powers second generic semaglutide nod in Canada

Approval marks the second generic semaglutide clearance in Canada and strengthens OneSource’s position in complex injectable CDMO programs


Lilly posts explosive Q1 2026 results
News | May 04, 2026

Lilly posts explosive Q1 2026 results

Lifts full-year outlook as obesity drug boom accelerates


Dr Reddy’s becomes first to secure Health Canada nod for generic Semaglutide injection
Drug Approval | May 01, 2026

Dr Reddy’s becomes first to secure Health Canada nod for generic Semaglutide injection

Market authorization for generic GLP-1 therapy strengthens company’s diabetes portfolio in Canada


OneSource Pharma, Dr Reddy’s secure Health Canada nod for generic Semaglutide
Drug Approval | April 29, 2026

OneSource Pharma, Dr Reddy’s secure Health Canada nod for generic Semaglutide

Approval for generic Semaglutide Injection strengthens CDMO partnership, enabling scalable supply from OneSource’s US FDA-approved Bengaluru facility


KIMS Hospitals Thane treats 88-Year-old PAD patient using advanced excimer laser atherectomy
Hospitals | April 24, 2026

KIMS Hospitals Thane treats 88-Year-old PAD patient using advanced excimer laser atherectomy

Minimally invasive laser-based procedure restores blood flow in complex arterial blockage, enables next-day discharge and improved mobility